Małgorzata Lisowska, Erin G Worrall, Filip Zavadil-Kokas, Keith Charlton, Euan Murray, M Aiman Mohtar, Radovan Krejcir, Vaclav Hrabal, Jack Brydon, Ainhoa Gonzalez Urionabarrenetxea, David G Saliba, Mariana Grima, Umesh Kalathiya, Petr Muller, Adam Krejci, Borivoj Vojtesek, Kathryn L Ball, Robin Fahraeus, David J Argyle, Maciej Parys, Ted R Hupp
{"title":"The development of a canine single-chain phage antibody library to isolate recombinant antibodies for use in translational cancer research.","authors":"Małgorzata Lisowska, Erin G Worrall, Filip Zavadil-Kokas, Keith Charlton, Euan Murray, M Aiman Mohtar, Radovan Krejcir, Vaclav Hrabal, Jack Brydon, Ainhoa Gonzalez Urionabarrenetxea, David G Saliba, Mariana Grima, Umesh Kalathiya, Petr Muller, Adam Krejci, Borivoj Vojtesek, Kathryn L Ball, Robin Fahraeus, David J Argyle, Maciej Parys, Ted R Hupp","doi":"10.1016/j.crmeth.2025.101008","DOIUrl":null,"url":null,"abstract":"<p><p>The development of canine immunotolerant monoclonal antibodies can accelerate the invention of new medicines for both canine and human diseases. We develop a methodology to clone the naive, somatically mutated variable domain repertoire from canine B cell mRNA using 5'RACE PCR. A set of degenerate primers were then designed and used to clone variable domain genes into archival \"holding\" plasmid libraries. These archived variable domain genes were then combinatorially ligated to produce a scFv M13 phage library. Next-generation long-read and short-read DNA sequencing methodologies were developed to annotate features of the cloned library including CDR diversity and IGHV/IGKV/IGLV subfamily distribution. A synthetic immunoglobulin G was developed from this scFv library to the canine immune checkpoint receptor PD-1. This synthetic platform can be used to clone and annotate archived antibody variable domain genes for use in perpetuity in order to develop improved preclinical models for the treatment of complex human diseases.</p>","PeriodicalId":29773,"journal":{"name":"Cell Reports Methods","volume":"5 3","pages":"101008"},"PeriodicalIF":4.3000,"publicationDate":"2025-03-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12049728/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cell Reports Methods","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.crmeth.2025.101008","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
引用次数: 0
Abstract
The development of canine immunotolerant monoclonal antibodies can accelerate the invention of new medicines for both canine and human diseases. We develop a methodology to clone the naive, somatically mutated variable domain repertoire from canine B cell mRNA using 5'RACE PCR. A set of degenerate primers were then designed and used to clone variable domain genes into archival "holding" plasmid libraries. These archived variable domain genes were then combinatorially ligated to produce a scFv M13 phage library. Next-generation long-read and short-read DNA sequencing methodologies were developed to annotate features of the cloned library including CDR diversity and IGHV/IGKV/IGLV subfamily distribution. A synthetic immunoglobulin G was developed from this scFv library to the canine immune checkpoint receptor PD-1. This synthetic platform can be used to clone and annotate archived antibody variable domain genes for use in perpetuity in order to develop improved preclinical models for the treatment of complex human diseases.